In the delayed group , antiretroviral treatment was initiated at a median CD@ count of @ ( IQR @-@ ) cells per L. Primary clinical events were reported in @ individuals assigned to early treatment initiation versus @ people allocated to delayed antiretroviral treatment ( hazard ratio @ , @ % CI @-@ ; p = @ ) .